Furthermore, tumor infiltrating NK cells expressing PD-1, TIGIT, TIM3 are relevant for therapeutic targeting in the context of checkpoint blockade of PD-1/PD-L1 axis. The gene discussed is HAVCR2; the disease is neoplasm.